# Chengdu Kanghua Biological Products

> Chengdu Kanghua Biological Products is a VC fund in Chengdu backing Biotechnology and Genetics. See 3 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Chengdu, China
- Total investments: 3
- Last investment: Aug 2023
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.kangh.com
- Facebook: https://facebook.com/Chengdu-Kanghua-Biological-Products-Co-Ltd-165357467341888

Chengdu Kanghua Biological Products is a VC fund in Chengdu focused on Biotechnology and Genetics. Kanghua Biological is a research and development, production, and operation of preventive biological products.The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 groupMeningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department.It was founded in 2004 in Chengdu, Sichuan, China.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Genetics | 2 | 67% |
| AgTech | 1 | 33% |
| Fitness | 1 | 33% |
| Wellness | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HC Scientific | HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system | $41.2M | Series B | Aug 28, 2023 | http://www.hcsci.com/ |
| Igenesis | Igenesis is a biotechnology company that provides molecular diagnostic technologies. | $15.8M | Series C | Mar 08, 2022 | http://www.igenesisbio.com/ |
| Abogen Biosciences | Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases. | $22.7M | Series A | Nov 05, 2020 | http://www.abogenbio.com/ |

3 of 3 investments shown.

## Co-investors
- [Dalton Venture](https://shizune.co/investors/profile/dalton-venture) — VC Fund, 1 deal together
- [Eightfold Venture Partners](https://shizune.co/investors/profile/eightfold-venture-partners) — VC Fund, 1 deal together
- [Guosheng Capital](https://shizune.co/investors/profile/guosheng-capital) — VC Fund, 1 deal together
- [Guotai Junan Securities](https://shizune.co/investors/profile/guotai-junan-securities) — VC Fund, 1 deal together
- [Hillhouse Investment](https://shizune.co/investors/profile/hillhouse-capital) — VC Fund, 1 deal together
- [Hillhouse Investment](https://shizune.co/investors/profile/hillhouse-investment) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)

## FAQ

### What does Chengdu Kanghua Biological Products invest in?

Chengdu Kanghua Biological Products invests primarily in Biotechnology, Genetics and AgTech startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chengdu Kanghua Biological Products last invest?

The most recent investment recorded for Chengdu Kanghua Biological Products closed in Aug 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co